Name: Metabolic Syndrome: A Comprehensive Update with New Insights
ISBN: 9789815322156

New!Websites for Authors

The co-op bookstore for avid readers

Metabolic Syndrome: A Comprehensive Update with New Insights

Hafize Uzun

Paperback

Regular price$98.00With free membership trial$73.0050% off your first book(max discount $25)+ Free shipping

In Stock– Ships within one business day

Do you recommend this book?

Yes!

The book focuses on a new interdisciplinary understanding of the metabolic syndrome (MetS) for better health maintenance. It provides an updated understanding of the underlying principles, possible targets, implementation approaches and the effectiveness of various avoidance strategies in MetS. The chapters cover a wide range of topics, including major advances in general aspects of metabolic syndrome, functional changes, new diagnostic methods, genotype-phenotype associations, the effect of exercise and multitarget pharmacotherapeutic strategies for MetS and perspectives on personalized medicine. It also discusses epigenetic mechanisms underlying MetS-related processes and epigenetic strategies to prevent related diseases. The book also presents summarized information about the associated factors and mechanisms linking cancer and MetS and to identify potential targets for the treatment of these patients. A better understanding of the various linkages will provide greater insight into the management of cancer patients by preventing MetS and related alterations.

Key Features

- Comprehensive information focused on the biological factors and physiological changes associated with metabolic syndrome

- Updates on metabolic syndrome diagnosis and management

- Summarized information on clinical implications for cancer therapy

- Thoroughly referenced chapters with summaries and discussions for quick understanding

The book is an informative resource for interdisciplinary scientists and researchers in life sciences and medicine. Furthermore, it, including the insulin-like growth factor (IGF-1) pathway, estrogen signaling, visceral adiposity, hyperinsulinemia, hyperglycemia, aromatase activity, adipokinase production, angiogenesis, oxidative stress, DNA damage and pro-inflammatory cytokines, and their clinical implications in cancer therapy.